Market Research

North America Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 127 Pages Knowledge Based Value (KBV) Research August, 2024 KBV19138442
Best Price Guarantee
Price from $1,500
Length 127 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date August, 2024
SKU KBV19138442

North America Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software and Services), By End-use, By Deployment, By Application, By Country and Growth Forecast, 2024 - 2031


The North America Clinical Risk Grouping Solution Market would witness market growth of 12.4% CAGR during the forecast period (2024-2031).

The US market dominated the North America Clinical Risk Grouping Solution Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $489.8 million by 2031. The Canada market is experiencing a CAGR of 14.8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 13.9% during (2024 - 2031).

A clinical risk grouping solution is a healthcare technology tool designed to categorize or "group" patients based on their risk of experiencing certain health outcomes, such as complications, hospitalizations, or the progression of chronic diseases.

Additionally, these solutions use various data inputs, including electronic health records (EHRs), claims data, demographic information, and sometimes social determinants of health, to analyze and stratify patients according to their risk levels.

North American healthcare providers are increasingly adopting these solutions to enhance patient outcomes, reduce healthcare costs, and comply with government regulations. Furthermore, the growing incidence of chronic diseases in the United States is a significant factor that is driving the demand for clinical risk classification systems. According to the Centers for Disease Control and Prevention (CDC), chronic disease affects 6 in 10 adults in the US, while 4 in 10 adults live with multiple chronic diseases. Chronic diseases represent one of the nation’s leading causes of disability and drivers of the nation’s $4.1 trillion in annual healthcare spending.

Based on Product, the market is segmented into Software and Services. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Long Term Care Centers, and Other. Based on Deployment, the market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. Based on Application, the market is segmented into Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • >Conduent, Incorporated
  • 3M Company
  • Oracle Corporation (Cerner Corporation)
  • Microsoft Corporation (Nuance Communications, Inc.)
  • Health Catalyst, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG (Siemens AG)
  • HBI Solutions
  • Lightbeam Health Solutions
  • Reveleer
North America Clinical Risk Grouping Solution Market Report Segmentation

By Product
  • >Software
  • Services
By End-use
  • >Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Long Term Care Centers
  • Other
By Deployment
  • >Private Cloud
  • Public Cloud
  • Hybrid Cloud
By Application
  • >Population Health Management
  • Chronic Disease Management
  • Clinical Decision Support
  • Fraud Detection and Prevention
  • Others
By Country
  • >US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Clinical Risk Grouping Solution Market, by Product
1.4.2 North America Clinical Risk Grouping Solution Market, by End-use
1.4.3 North America Clinical Risk Grouping Solution Market, by Deployment
1.4.4 North America Clinical Risk Grouping Solution Market, by Application
1.4.5 North America Clinical Risk Grouping Solution Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities:
3.2.4 Market Challenges:
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar – 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Clinical Risk Grouping Solution Market by Product
5.1 North America Software Market by Region
5.2 North America Services Market by Region
Chapter 6. North America Clinical Risk Grouping Solution Market by End-use
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Ambulatory Surgical Centers Market by Country
6.3 North America Long Term Care Centers Market by Country
6.4 North America Other Market by Country
Chapter 7. North America Clinical Risk Grouping Solution Market by Deployment
7.1 North America Private Cloud Market by Country
7.2 North America Public Cloud Market by Country
7.3 North America Hybrid Cloud Market by Country
Chapter 8. North America Clinical Risk Grouping Solution Market by Application
8.1 North America Population Health Management Market by Country
8.2 North America Chronic Disease Management Market by Country
8.3 North America Clinical Decision Support Market by Country
8.4 North America Fraud Detection and Prevention Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Clinical Risk Grouping Solution Market by Country
9.1 US Clinical Risk Grouping Solution Market
9.1.1 US Clinical Risk Grouping Solution Market by Product
9.1.2 US Clinical Risk Grouping Solution Market by End-use
9.1.3 US Clinical Risk Grouping Solution Market by Deployment
9.1.4 US Clinical Risk Grouping Solution Market by Application
9.2 Canada Clinical Risk Grouping Solution Market
9.2.1 Canada Clinical Risk Grouping Solution Market by Product
9.2.2 Canada Clinical Risk Grouping Solution Market by End-use
9.2.3 Canada Clinical Risk Grouping Solution Market by Deployment
9.2.4 Canada Clinical Risk Grouping Solution Market by Application
9.3 Mexico Clinical Risk Grouping Solution Market
9.3.1 Mexico Clinical Risk Grouping Solution Market by Product
9.3.2 Mexico Clinical Risk Grouping Solution Market by End-use
9.3.3 Mexico Clinical Risk Grouping Solution Market by Deployment
9.3.4 Mexico Clinical Risk Grouping Solution Market by Application
9.4 Rest of North America Clinical Risk Grouping Solution Market
9.4.1 Rest of North America Clinical Risk Grouping Solution Market by Product
9.4.2 Rest of North America Clinical Risk Grouping Solution Market by End-use
9.4.3 Rest of North America Clinical Risk Grouping Solution Market by Deployment
9.4.4 Rest of North America Clinical Risk Grouping Solution Market by Application
Chapter 10. Company Profiles
10.1 Conduent, Incorporated
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.2 3M Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Oracle Corporation (Cerner Corporation)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Microsoft Corporation (Nuance Communications, Inc.)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.6 SWOT Analysis
10.5 Health Catalyst, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Acquisition and Mergers:
10.5.6 SWOT Analysis
10.6 Koninklijke Philips N.V.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.6.5.2 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 HBI Solutions
10.8.1 Company Overview
10.9 Lightbeam Health Solutions
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Acquisition and Mergers:
10.10. Reveleer
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Acquisition and Mergers:

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings